Artificial saliva market seen reaching $3.97B by 2030

The artificial saliva market is projected to grow from $2.21 billion in 2025 to $3.97 billion by 2030, driven by rising dry mouth cases, cancer treatment side effects and aging populations. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Artificial saliva is a treatment option for xerostomia, or chronic dry mouth, which can affect chewing, swallowing and oral comfort. - Demand is rising as more people use medications linked to dry mouth and as cancer care continues to create need for saliva substitutes. - The market's growth points to broader adoption of products that improve quality of life for patients with oral dryness.

What happened: - The Business Research Company projected the artificial saliva market will grow from $2.21 billion in 2025 to $2.51 billion in 2026. - The report forecasts the market will reach $3.97 billion by 2030. - The report cites a 13.6% CAGR for 2026 and a 12.2% CAGR through 2030. - The company published a free sample and the full report online: More information and the full report.

The details: - Rising dry mouth syndrome is a primary driver of market growth. - Xerostomia has become more common because of an aging population and medications that can cause dry mouth. - The report says the US National Institutes of Health reported via PubMed in 2025 that pooled xerostomia prevalence was about 38%, with a confidence interval of 22% to 57%. - Artificial saliva products are designed to mimic natural saliva and moisten the oral cavity. - The products are used for dry mouth linked to Sjögren's syndrome, radiation therapy for cancer and certain medications. - The report says future growth will be supported by aging populations, therapies focused on quality of life, pediatric-friendly formulations, bio-mimetic saliva products and wider distribution through healthcare and retail outlets. - Expected trends include xerostomia management products, alcohol-free oral formulations, patient-centric dosage forms, ready-to-use saliva products, and a stronger focus on oral comfort and hydration.

Between the lines: - The forecast suggests artificial saliva is shifting from a niche supportive product to a broader oral-care category. - Product development appears to be moving toward easier, more patient-friendly formats rather than purely clinical formulations. - North America's current lead reflects established healthcare access and awareness, while faster Asia-Pacific growth signals expanding demand in newer markets.

What's next: - North America is expected to remain the largest regional market in 2025. - Asia-Pacific is expected to grow the fastest over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspot infographics and updated graphics and tables.

The bottom line: - Artificial saliva is on track for strong double-digit growth through 2030 as dry mouth treatment demand expands worldwide.